Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Assessing barriers to healthy eating in hospitalized older adults with heart failure: psychometric properties of two questionnaires.

Marolt C, Miller A, Carlozzi NE, Karmally W, Helmke S, Teruya S, Wells J, Trumble E, Maurer MS, Hummel SL.

J Card Fail. 2019 Sep 30. pii: S1071-9164(19)30031-4. doi: 10.1016/j.cardfail.2019.09.011. [Epub ahead of print]

PMID:
31580890
2.

Assessing hepatic impairment in Fontan-associated liver disease using the HepQuant SHUNT test.

Lemmer A, VanWagner L, Gasanova Z, Helmke S, Everson GT, Ganger D.

Congenit Heart Dis. 2019 Aug 1. doi: 10.1111/chd.12831. [Epub ahead of print]

PMID:
31369200
3.

Days alive and outside of hospital from diagnosis of transthyretin vs. light chain cardiac amyloidosis.

Rubin J, Teruya S, Helmke S, De Los Santos J, Alvarez J, Maurer MS.

Amyloid. 2019;26(sup1):4-5. doi: 10.1080/13506129.2019.1582017. No abstract available.

PMID:
31343342
4.

Facilitated Peer Mentorship to Support Aging Research: A RE-AIM Evaluation of the CoMPAdRE Program.

Masterson Creber RM, Baldwin MR, Brown PJ, Rao MK, Goyal P, Hummel S, Dodson JA, Helmke S, Maurer MS.

J Am Geriatr Soc. 2019 Apr;67(4):804-810. doi: 10.1111/jgs.15792. Epub 2019 Jan 29.

5.

Home-Delivered Meals Postdischarge From Heart Failure Hospitalization.

Hummel SL, Karmally W, Gillespie BW, Helmke S, Teruya S, Wells J, Trumble E, Jimenez O, Marolt C, Wessler JD, Cornellier ML, Maurer MS.

Circ Heart Fail. 2018 Aug;11(8):e004886. doi: 10.1161/CIRCHEARTFAILURE.117.004886.

6.

TTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac Amyloidosis.

Rosenblum H, Castano A, Alvarez J, Goldsmith J, Helmke S, Maurer MS.

Circ Heart Fail. 2018 Apr;11(4):e004769. doi: 10.1161/CIRCHEARTFAILURE.117.004769.

7.

Can a Left Ventricular Assist Device in Individuals with Advanced Systolic Heart Failure Improve or Reverse Frailty?

Maurer MS, Horn E, Reyentovich A, Dickson VV, Pinney S, Goldwater D, Goldstein NE, Jimenez O, Teruya S, Goldsmith J, Helmke S, Yuzefpolskaya M, Reeves GR.

J Am Geriatr Soc. 2017 Nov;65(11):2383-2390. doi: 10.1111/jgs.15124. Epub 2017 Sep 21.

8.

Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?

Rubin J, Alvarez J, Teruya S, Castano A, Lehman RA, Weidenbaum M, Geller JA, Helmke S, Maurer MS.

Amyloid. 2017 Dec;24(4):226-230. doi: 10.1080/13506129.2017.1375908. Epub 2017 Sep 14.

PMID:
28906148
9.

Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients.

Schonhoft JD, Monteiro C, Plate L, Eisele YS, Kelly JM, Boland D, Parker CG, Cravatt BF, Teruya S, Helmke S, Maurer M, Berk J, Sekijima Y, Novais M, Coelho T, Powers ET, Kelly JW.

Sci Transl Med. 2017 Sep 13;9(407). pii: eaam7621. doi: 10.1126/scitranslmed.aam7621.

10.

Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy).

Cho Y, Baranczak A, Helmke S, Teruya S, Horn EM, Maurer MS, Kelly JW.

Amyloid. 2015;22(3):175-80. doi: 10.3109/13506129.2015.1063485. Epub 2015 Jul 25.

11.

Noninvasive assessment of liver function.

Helmke S, Colmenero J, Everson GT.

Curr Opin Gastroenterol. 2015 May;31(3):199-208. doi: 10.1097/MOG.0000000000000167. Review.

12.

The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis.

Tendler A, Helmke S, Teruya S, Alvarez J, Maurer MS.

Amyloid. 2015 Mar;22(1):61-6. doi: 10.3109/13506129.2014.994202. Epub 2014 Dec 16.

PMID:
25510353
13.

Cardiovascular effects of hemoglobin response in patients receiving epoetin alfa and oral iron in heart failure with a preserved ejection fraction.

Vullaganti S, Goldsmith J, Teruya S, Alvarez J, Helmke S, Maurer MS.

J Geriatr Cardiol. 2014 Jun;11(2):100-5. doi: 10.3969/j.issn.1671-5411.2014.02.002.

14.

Quantification of transthyretin kinetic stability in human plasma using subunit exchange.

Rappley I, Monteiro C, Novais M, Baranczak A, Solis G, Wiseman RL, Helmke S, Maurer MS, Coelho T, Powers ET, Kelly JW.

Biochemistry. 2014 Apr 1;53(12):1993-2006. doi: 10.1021/bi500171j. Epub 2014 Mar 24.

15.

Differences in blood volume components between hyporesponders and responders to erythropoietin alfa: the heart failure with preserved ejection fraction (HFPEF) anemia trial.

Borovka M, Teruya S, Alvarez J, Helmke S, Maurer MS.

J Card Fail. 2013 Oct;19(10):685-91. doi: 10.1016/j.cardfail.2013.08.508.

16.

Somatostatin, estrogen, and polycystic liver disease.

Everson GT, Helmke SM.

Gastroenterology. 2013 Aug;145(2):279-82. doi: 10.1053/j.gastro.2013.06.025. Epub 2013 Jun 24. No abstract available.

PMID:
23806538
17.

Impact of epoetin alfa on left ventricular structure, function, and pressure volume relations as assessed by cardiac magnetic resonance: the heart failure preserved ejection fraction (HFPEF) anemia trial.

Green P, Babu BA, Teruya S, Helmke S, Prince M, Maurer MS.

Congest Heart Fail. 2013 Jul-Aug;19(4):172-9. doi: 10.1111/chf.12027. Epub 2013 Mar 20.

18.

Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy.

Maurer MS, Teruya S, Chakraborty B, Helmke S, Mancini D.

Circ Heart Fail. 2013 Mar;6(2):254-63. doi: 10.1161/CIRCHEARTFAILURE.112.969717. Epub 2012 Dec 20.

19.

Diflunisal for ATTR cardiac amyloidosis.

CastaƱo A, Helmke S, Alvarez J, Delisle S, Maurer MS.

Congest Heart Fail. 2012 Nov-Dec;18(6):315-9. doi: 10.1111/j.1751-7133.2012.00303.x. Epub 2012 Jul 2.

20.

A dosing algorithm for erythropoietin alpha in older adults with heart failure and a preserved ejection fraction.

Altincatal A, Macarthur RB, Teruya S, Helmke S, Maurer MS.

Cardiovasc Ther. 2013 Apr;31(2):92-9. doi: 10.1111/j.1755-5922.2011.00295.x. Epub 2011 Aug 26.

21.

Blood volume measurements in patients with heart failure and a preserved ejection fraction: implications for diagnosing anemia.

Noumi B, Teruya S, Salomon S, Helmke S, Maurer MS.

Congest Heart Fail. 2011 Jan-Feb;17(1):14-8. doi: 10.1111/j.1751-7133.2010.00208.x. Epub 2011 Jan 24.

22.

Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).

Bhuiyan T, Helmke S, Patel AR, Ruberg FL, Packman J, Cheung K, Grogan D, Maurer MS.

Circ Heart Fail. 2011 Mar;4(2):121-8. doi: 10.1161/CIRCHEARTFAILURE.109.910455. Epub 2010 Dec 29.

23.

Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failure.

Rosenblum H, Helmke S, Williams P, Teruya S, Jones M, Burkhoff D, Mancini D, Maurer MS.

Congest Heart Fail. 2010 Nov-Dec;16(6):254-8. doi: 10.1111/j.1751-7133.2010.00187.x. Epub 2010 Oct 19.

24.

Protein kinase C-related kinase targets nuclear localization signals in a subset of class IIa histone deacetylases.

Harrison BC, Huynh K, Lundgaard GL, Helmke SM, Perryman MB, McKinsey TA.

FEBS Lett. 2010 Mar 19;584(6):1103-10. doi: 10.1016/j.febslet.2010.02.057. Epub 2010 Feb 24.

25.

Facilitating clinical trials of anemia in older adults: a point-of-care system to measure hemoglobin in the home and its agreement with a hospital core laboratory.

Teruya SL, Gil HR, Teresi JA, Kong J, Eimicke J, Helmke S, Maurer MS.

J Am Geriatr Soc. 2009 Dec;57(12):2362-4. No abstract available.

26.

Discovery and verification of protein differences between Er positive/Her2/neu negative breast tumor tissue and matched adjacent normal breast tissue.

Weitzel LR, Byers T, Allen J, Finlayson C, Helmke SM, Hokanson JE, Hunsucker SW, Murphy JR, Newell K, Queensland KM, Singh M, Wischmeyer PE, Duncan MW, Elias A.

Breast Cancer Res Treat. 2010 Nov;124(2):297-305. doi: 10.1007/s10549-009-0721-6. Epub 2010 Jan 20.

PMID:
20087651
27.

Overestimation of left ventricular mass and misclassification of ventricular geometry in heart failure patients by two-dimensional echocardiography in comparison with three-dimensional echocardiography.

Abramov D, Helmke S, Rumbarger Lel-K, King DL, Maurer MS.

Echocardiography. 2010 Mar;27(3):223-9. doi: 10.1111/j.1540-8175.2009.01004.x. Epub 2009 Jan 13.

PMID:
20070363
28.

Advances in management of polycystic liver disease.

Everson GT, Helmke SM, Doctor B.

Expert Rev Gastroenterol Hepatol. 2008 Aug;2(4):563-76. doi: 10.1586/17474124.2.4.563. Review.

PMID:
19072404
29.

Discovery and validation of protein abundance differences between follicular thyroid neoplasms.

Netea-Maier RT, Hunsucker SW, Hoevenaars BM, Helmke SM, Slootweg PJ, Hermus AR, Haugen BR, Duncan MW.

Cancer Res. 2008 Mar 1;68(5):1572-80. doi: 10.1158/0008-5472.CAN-07-5020.

30.

Calpain inhibition attenuates right ventricular contractile dysfunction after acute pressure overload.

Greyson CR, Schwartz GG, Lu L, Ye S, Helmke S, Xu Y, Ahmad H.

J Mol Cell Cardiol. 2008 Jan;44(1):59-68. Epub 2007 Oct 23.

31.

Measurement of the NO metabolites, nitrite and nitrate, in human biological fluids by GC-MS.

Helmke SM, Duncan MW.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 May 15;851(1-2):83-92. Epub 2006 Oct 27. Review.

PMID:
17070739
32.

Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.

Brown LM, Helmke SM, Hunsucker SW, Netea-Maier RT, Chiang SA, Heinz DE, Shroyer KR, Duncan MW, Haugen BR.

Mol Carcinog. 2006 Aug;45(8):613-26.

33.

Myotonic dystrophy protein kinase monoclonal antibody generation from a coiled-coil template.

Helmke SM, Lu SM, Harmon M, Glasford JW, Larsen TD, Kwok SC, Hodges RS, Perryman MB.

J Mol Recognit. 2006 May-Jun;19(3):215-26.

PMID:
16680721
34.

Estrogen regulation of the rat anterior pituitary gland proteome.

Blake CA, Brown LM, Duncan MW, Hunsucker SW, Helmke SM.

Exp Biol Med (Maywood). 2005 Dec;230(11):800-7.

PMID:
16339744
35.

Proteomics of the anterior pituitary gland as a model for studying the physiology of a heterogeneous organ.

Blake CA, Helmke SM.

Exp Biol Med (Maywood). 2005 Dec;230(11):793-9. Review.

PMID:
16339743
36.

Quantitative analysis of proteomics using data mining. An automated system for constructing assays quickly and precisely.

Yen CY, Helmke SM, Cios KJ, Perryman MB, Duncan MW.

IEEE Eng Med Biol Mag. 2005 May-Jun;24(3):67-72. No abstract available.

PMID:
15971843
37.

The Ku protein complex interacts with YY1, is up-regulated in human heart failure, and represses alpha myosin heavy-chain gene expression.

Sucharov CC, Helmke SM, Langer SJ, Perryman MB, Bristow M, Leinwand L.

Mol Cell Biol. 2004 Oct;24(19):8705-15.

38.

Simultaneous quantification of human cardiac alpha- and beta-myosin heavy chain proteins by MALDI-TOF mass spectrometry.

Helmke SM, Yen CY, Cios KJ, Nunley K, Bristow MR, Duncan MW, Perryman MB.

Anal Chem. 2004 Mar 15;76(6):1683-9.

PMID:
15018568
39.

Analysis of myosin heavy chain functionality in the heart.

Krenz M, Sanbe A, Bouyer-Dalloz F, Gulick J, Klevitsky R, Hewett TE, Osinska HE, Lorenz JN, Brosseau C, Federico A, Alpert NR, Warshaw DM, Perryman MB, Helmke SM, Robbins J.

J Biol Chem. 2003 May 9;278(19):17466-74. Epub 2003 Mar 6.

40.

Hypoplastic left heart syndrome myocytes are differentiated but possess a unique phenotype.

Bohlmeyer TJ, Helmke S, Ge S, Lynch J, Brodsky G, Sederberg JH, Robertson AD, Minobe W, Bristow MR, Perryman MB.

Cardiovasc Pathol. 2003 Jan-Feb;12(1):23-31.

PMID:
12598014
41.

Myotonic dystrophy protein kinase domains mediate localization, oligomerization, novel catalytic activity, and autoinhibition.

Bush EW, Helmke SM, Birnbaum RA, Perryman MB.

Biochemistry. 2000 Jul 25;39(29):8480-90.

PMID:
10913253
42.

Phospholemman is a substrate for myotonic dystrophy protein kinase.

Mounsey JP, John JE 3rd, Helmke SM, Bush EW, Gilbert J, Roses AD, Perryman MB, Jones LR, Moorman JR.

J Biol Chem. 2000 Jul 28;275(30):23362-7.

43.

SRC binding to the cytoskeleton, triggered by growth cone attachment to laminin, is protein tyrosine phosphatase-dependent.

Helmke S, Lohse K, Mikule K, Wood MR, Pfenninger KH.

J Cell Sci. 1998 Aug;111 ( Pt 16):2465-75.

44.

Axonal origin and purity of growth cones isolated from fetal rat brain.

Lohse K, Helmke SM, Wood MR, Quiroga S, de la Houssaye BA, Miller VE, Negre-Aminou P, Pfenninger KH.

Brain Res Dev Brain Res. 1996 Oct 23;96(1-2):83-96.

PMID:
8922671
45.

Growth cone enrichment and cytoskeletal association of non-receptor tyrosine kinases.

Helmke S, Pfenninger KH.

Cell Motil Cytoskeleton. 1995;30(3):194-207.

PMID:
7758136
46.

Growth-regulated proteins and neuronal plasticity. A commentary.

Pfenninger KH, de la Houssaye BA, Helmke SM, Quiroga S.

Mol Neurobiol. 1991;5(2-4):143-51. Review.

PMID:
1823138
47.

Solubilization of stable adenosine A1 receptors from rat brain.

Helmke SM, Cooper DM.

Biochem J. 1989 Jan 15;257(2):413-8.

Supplemental Content

Loading ...
Support Center